 Lipid binding protein 4 |
| 1. An isolated polypeptide selected from one of the groups consisting of: (a) a polypeptide encoded ... |
|
| Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies |
| OF THE PREFERRED EMBODIMENTS I. Definitions An "ErbB receptor" is a receptor protein tyrosine ... |
|
| Tumor killing effects of enterotoxins, superantigens, and related compounds |
| What is claimed is: 1. A mammalian cell comprising an exogenous nucleic acid encoding a ... |
|
| Vaccine against Staphylococcus intoxication |
| The present invention satisfies the need discussed above. The present invention relates to a method ... |
|
| Mutants of Streptococcal toxin C and methods of use |
| OF THE INVENTION This invention is directed to mutant SPE-C toxins and fragments thereof, vaccine ... |
|
| Mutants of Streptococcal toxin A and methods of use |
| OF THE INVENTION This invention is directed to mutant SPE-A toxins and fragments thereof, vaccine ... |
|
| Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
| It has now been surprisingly found that polarisation of the T.sub.H1 immune response over the T.sub.... |
|
| Chemiluminescent compounds and methods of use |
| What is claimed is: 1. A compound of the formula: ##STR32## wherein: X is NH and Y is independently ... |
|
|
Trichothecene antibody conjugates
| Details |
Inventors: Pavanasasivam, Gowsala;
Assignee: NeoRx Corporation (Seattle, WA)
Primary Examiner: Rosen; Sam
Assistant Examiner:
Attorney, Agent or Firm: Seed and Berry
Conjugates of trichothecenes and agents that bind to a defined population of cells are disclosed. Preferred are conjugates of trichothecene molecules with polyclonal or monoclonal antibodies or fragments thereof that recognize antigens that are present only on tumor cells or are augmented in their expression on tumor cells as compared to normal tissues. Trichothecene molecules are coupled to the agent through non-covalent and covalent linkages, such as peptide bonds, disulfide bonds, thioester bonds, or thioether bonds. A method for inhibiting the growth and metabolism of antigen-positive cells is also disclosed. |
|
DETAILED DESCRIPTION I claim: 1.
A conjugate of a trichothecene and an antibody or antibody fragment, said antibody or antibody fragment being capable of specifically binding to a defined population of cells.
2.
The conjugate of claim 1 wherein said trichothecene has a central sesquiterpenoid structure.
3.
The conjugate of claim 2 wherein said trichothecene has an additional macrocyclic ring.
4.
The conjugate of claim 2 wherein said trichothecene is selected from the group consisting of trichodermol, verrucarol, trichodermin, anguidine, and T-2 toxin.
5.
The conjugate of claim 3 wherein said trichothecene is selected from the group consisting of verrucarin A, verrucarin B, verrucarin J, 2'-dehydroverrucarin A, roridin A, roridin D, roridin E, roridin H, satratoxin F, satratoxin G, satratoxin H, vertisporin, and baccharins.
6.
The conjugate of claim 1 wherein the trichothecene is verrucarol.
7.
The conjugate of claim 1 wherein the trichothecene is verrucarin A.
8.
The conjugate of claim 1 wherein said trichothecene mycotoxin comprises the formula: ##STR28## wherein: R.
sub.
1 is H, OH, or ##STR29## R.
sub.
2 is H, OH, ##STR30## R.
sub.
3 is H, OH, or ##STR31## R.
sub.
4 is H, OH, .
dbd.
O, ##STR32## 9.
The conjugate of claim 8 wherein R.
sub.
4 comprises an epoxide group.
10.
The conjugate of claim 1 wherein said trichothecene comprises the formula: ##STR33## wherein: R.
sub.
1 is OH, or ##STR34## R.
sub.
2 is H, OH, ##STR35## or OCOCH.
sub.
2 CH(CH.
sub.
3).
sub.
2 ; and R' is: ##STR36## 11.
The conjugate of claim 1 wherein said antibody comprises monoclonal antibodies.
12.
The conjugate of claim 11 wherein the monoclonal antibodies are of human or other warm blooded animal origin.
13.
The conjugate of claim 1 wherein said antibody comprises polyclonal antibodies.
14.
The conjugate of claim 1 wherein said defined population of cells comprises tumor cells.
15.
The conjugate of claim 1 wherein said defined population of cells comprises cells bearing tumor-associated antigens.
16.
The conjugate of claim 1 wherein said trichothecene and said antibody or antibody fragment are coupled through a covalent linkage
|
| Related patents |
|
|
Monoclonal antibody to human protein C
What is claimed is: 1. A monoclonal antibody which is specific to human protein C which has calcium bound at the gamma-carboxyglutamic acid (Gla) domain and does not ...
|
|
|
Method for providing a cell culture from a transgenic non-human mammal
We claim: 1. A method of providing a cell culture comprising (1) providing a transgenic non-human mammal, all of whose germ cells and somatic cells contain a recombinant ...
|
|
|
Method of gene transfer into chickens and other avian species
A method is described for introducing foreign genes or foreign nucleic acid sequences into somatic and/or germ cells of the chicken and other avian species. A ...
|
|
|
DNA vector with isolated CDNA gene encoding metallopanstimulin
The present invention is based upon the discovery of a new and heretofore unrecognized type of cellular mRNA sequence and its encoded protein, designated as ...
|
|
|
Method for preparing immunoglobulin fragments
Pursuant to the present invention, there is provided an improved method for specific fragmentation of immunoglobulins and recovery of the fragments. Through the use of ...
|
|
|
Morpholino-subunit combinatorial library and method
The invention includes, in one aspect, a combinatorial library of non-biological oligomers formed predominantly of morpholino subunit structures of the form: ##STR1## ...
|
|
|
Method of producing transgenic animals
What is claimed is: 1. A method for transferring DNA into fertilized eggs of a non-human mammal, comprising: subjecting a mixture of said DNA and said fertilized eggs to ...
|
|
|
Humanized immunoglobulins
OF THE INVENTION In accordance with the present invention, novel means of designing humanized immunoglobulins capable of specifically binding to a predetermined antigen ...
|
|
|
Recombinant retroviruses
Briefly stated, the present invention provides recombinant retroviruses carrying a vector construct capable of preventing, inhibiting, stabilizing or reversing ...
|
|
|
Transgenic bovine
In accordance with the above objects, the invention includes transgenes for producing recombinant polypeptides in the milk of transgenic bovine species. The production ...
|
|
|
Drugs 
